Related Experiment Videos
Prospective randomized studies are needed to define the role of axillary lymph node dissection in primary breast
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer.
Breast cancer research and treatment·2017
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial.
Breast cancer research and treatment·2017
P-Loop/αC-Helix Compressing Mutations and Exon 20 Insertions in EGFR-Mutant NSCLC: A Rapidly Evolving Therapeutic Landscape.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early-Stage Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
An etiological approach to psychosis: potential benefits for treatment, research and prevention.
World psychiatry : official journal of the World Psychiatric Association (WPA)·2026
[Use of predictive models for assessing perioperative outcomes of surgical treatment of localized renal parenchymal tumors: a critical review].
Urologiia (Moscow, Russia : 1999)·2026
[Confocal laser endomicroscopy as a tool for intraoperative risk stratification of upper tract urothelial carcinoma].
Urologiia (Moscow, Russia : 1999)·2026
[Genes determining virulence factors of Escherichia coli strains isolated from prostate secretions patients with chronic bacterial prostatitis].
Urologiia (Moscow, Russia : 1999)·2026
YTHDF3 Promoted Gastric Cancer Progression by Facilitating m6A-Dependent Degradation of APC mRNA.
Analytical cellular pathology (Amsterdam)·2026
Palliative Care Utilization in Mesothelioma: Insights from the National Inpatient Sample (2016-2020).
Journal of palliative care·2026